Blog
If You Invested $1,000 in Cronos Group's IPO, Here's the Staggering Amount of Money You'd Have Now
You know Aphria and Aurora Cannabis, Canopy Growth and Tilray, but do you recall the best-performing marijuana stock of them all? It's none other than Cronos Group (NASDAQ: CRON), the pot stock
It's Now Abundantly Clear: Canopy Growth Is in a Different League From Aurora Cannabis
I've tended to lump Aurora Cannabis (NYSE: ACB) and Canopy Growth (NYSE: CGC) together as the top-tier players in the Canadian cannabis industry. And to some extent, that grouping was right. Both
Better Marijuana Stock: Charlotte's Web Holdings vs. Green Thumb Industries
Forget Canada, the U.S. is where the big story is when it comes to cannabis. For one thing, the U.S. cannabis market is much bigger than Canada's. There are also more opportunities for growth, with
Social Security Is Not Going Bankrupt, but Don't Count on It Anyway
There are many rumors that Social Security is on the verge of bankruptcy, and that it won't be able to pay benefits to seniors in the not-so-distant future. The good news, however, is that these
The Top 3 Reasons You're Not Saving -- and What to Do About Each One
On American Ninja Warrior, competitors tackle a series of obstacles that challenge their physical strength and problem-solving skills. Rest assured, those obstacles are vastly more difficult to
Oil Companies Are Starving for Air
National Oilwell Varco (NYSE: NOV) has its finger firmly on the pulse of the oil industry. As the sector's leading oil-field equipment manufacturer, it's in constant contact with its customers and
7 Simple Tricks for Saving More Money
Most of us would probably like to be saving more money, as most people have not saved very much for retirement. About half of people aged 35 to 44 have less than $25,000 saved for retirement, per
You've Never Heard of My Favorite High-Yield Bank Stock. Here's Why It's a Buy Right Now.
Bank of N.T. Butterfield & Son (NYSE: NTB) reported fourth-quarter results on Feb. 12, banking another solid quarter. Earnings were down, falling from $3.50 per share in 2018 to $3.30 in 2019, as
The Most Important Number to Look at Before Buying a Pot Stock
When a company releases its earnings report, two main items are typically the focus for analysts and investors -- revenue and earnings. While those are important numbers to keep an eye on, they may
Better Buy: Biogen vs. Bristol-Myers Squibb
You don't have to look back too far to find a time when Biogen (NASDAQ: BIIB) and Bristol-Myers Squibb (NYSE: BMY) claimed very similar market caps. That was the case in the spring of 2015. Since
Can A.O. Smith Weather Another China Headwind?
A.O. Smith (NYSE: AOS) isn't a household name for investors, but maybe it should be after 26 consecutive years of dividend increases. The average annual dividend increase over the last decade was
This Simple Tax Move Can Spare You Penalties
The simplest of dance moves is the head nod -- it'll get you through any wedding without embarrassment. And the simplest of tax moves? Reviewing your W-4 annually to get through any tax year without
These 3 Common Retirement Problems All Have the Same Simple Solution
The challenges you face in retirement might differ than those your neighbor or former colleague struggles with. But there are certain universal issues that seniors tend to grapple with, and these
The Odds Are Heavily in Your Favor If You Claim Social Security at This Age
You may not realize it, but there's a very good chance that you'll be reliant on Social Security, to some degree, to make ends meet during retirement. According to Gallup's April 2019 surveys, a
Pay Off Your Mortgage Early or Invest? How I'm Using Dividend Stocks to Get Ahead
One of the first pieces of financial advice you'll hear is "get out of debt," and frankly it's excellent advice in almost every situation. That's particularly true for high-interest debt like credit
Where Does AT&T TV Fit Into the Pay-TV Market?
Subscriber losses have come to be expected in the legacy pay-TV space. Cable and satellite subscriptions are less popular with consumers every year. Speaking broadly, you can connect the
Is This 14% Yield a Dividend Trap or an Unbeatable Buy?
Units of MLP Noble Midstream Partners (NYSE: NBLX) have tumbled nearly 40% over the past year, which has pushed the yield on its distribution up to an eye-popping 14%. Investors have bailed on the
3 Top Energy Stocks to Buy in February
As easy as it sounds, it is quite difficult to follow the 'buy low, sell high' idea. It's tough to go against the collective wisdom of investors who don't like a sector or stock. This is the case
Report: Stress Might Be Killing Your Finances
No matter what your financial situation looks like, most people will experience stress from time to time. However, for many adults, financial stress is at a dangerous high.
Approximately 58% of
Tesla Model S Now Boasts Up to 390 Miles of Range
All Model S and X vehicles delivered in recent months actually have more driving range on a single charge than Tesla (NASDAQ: TSLA) let on, CEO Elon Musk said on Twitter this weekend. Specifically
Despite a Fat Dividend, Kraft Heinz Is a Terrible Investment
Kraft Heinz (NASDAQ: KHC) offers investors a huge 5.3% dividend yield at a time when the broader market's yield is below 2%. It operates in the largely stable food industry, offering name-brand
Glu Mobile Surged on Earnings: Is It Time to Believe in the Turnaround?
Glu Mobile (NASDAQ: GLUU) is rallying from its 2019 lows. The stock saw a 26% spike on Feb. 6 following an earnings and revenue beat for the fourth quarter of 2019. Though it has given back some of
This Renewable Energy Stock Has Plenty of Power to Keep Growing its High-Yielding Payout
Brookfield Renewable Partners (NYSE: BEP) has an excellent track record of rewarding its investors. Since its formation in 1999, the renewable energy producer has grown its distribution at a 6%
Why Spotify Is Cheaper Than You Think
Spotify (NYSE: SPOT) looks like another richly valued tech stock, but it's a lot cheaper than you think. Here's why: It has an enormous addressable opportunity ahead, it is by far the most
Is Insulet a Buy?
While cutting-edge technologies such as gene-editing and cancer immunology tend to get a lot of attention in the biotech world, one of the most lucrative niches in this area comes from treating a


